Clinical Trial

Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.

Study acronym: MCPEPAG
Completed Phase 4
View on ClinicalTrials.gov →
Summary
Background: Age specific mortality rate (ASMR) of 16-60 years is very high in Indian tribal areas due to communicable and non-communicable diseases. Objectives: The primary objective is to reduce the ASMR in 16-60 years age group by at-least 30% from 16 tribal villages of Melghat. The secondary objectives are to reduce cause-specific mortality rates (CSMR) in 16-60 years age group because of diarrhoea, malaria, pneumonia, etc. Design: Community-based, single-centered, parallel-arm, cluster randomised controlled trial. Setting: 36 tribal villages/clusters (research phase: 2004-2015) and 44 new villages (replication phase: 2016-2022) were externally randomized by lottery method to intervention arm (IA) or control arm (CA). Participants: All persons in age group of 16-60 years from inaccessible 80 tribal villages. Interventions: Trained VHWs in IA, provided behaviour change communication, treatment and referral. Except principal investigator, other study staff and participants were double blinded.
Trial Details
NCT Number NCT07436104
Lead Sponsor MAHAN Trust
Collaborators: Caring Friends, Mumbai, Stitchting Geron, The Netherland, Mastek Foundation, Tribal Development Department, Government of India
Conditions Hypertension (HTN), Diarrhea, Pneumonia, Malaria Fever, COPD, Asthma (Diagnosis), Diarrhea Chronic
Enrollment 72,564 participants
Start Date 2004-01-01
Primary Completion 2015-12-31 (estimated)
Study Completion 2023-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-27